Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
IGM Biosciences, Inc.
TopAlliance Biosciences
Valerio Therapeutics
Valerio Therapeutics
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center